Previous Article | Next Article 
Journal of Virology, April 2003, p. 4457-4462, Vol. 77, No. 7
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.7.4457-4462.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Use of Transgenic HLA A*0201/Kb and HHD II Mice To Evaluate Frequency of Cytomegalovirus IE1-Derived Peptide Usage in Eliciting Human CD8 Cytokine Response
Ghislaine Gallez-Hawkins,1 Maria C. Villacres,2 Xiuli Li,1 Margaret C. Sanborn,1 Norma A. Lomeli,1 and John A. Zaia1*
Department of Virology, Beckman Research Institute of the City of Hope, Duarte,1
Department of Pediatrics, University of Southern California, Los Angeles, California2
Received 1 November 2002/
Accepted 3 January 2003
Unlike the pp65 protein of human cytomegalovirus (CMV), which has an immunodominant peptide, pp65495-503, recognized by human CD8+ cells in the context of HLA A*0201, the fine peptide specificity for CMV IE1 has shown no such immunodominance. With the use of transgenic HLA A*0201/Kb and HHD II mice, a selected pool of IE1 peptides, including IE1p256-264, IE1p297-304, and IE1p316-324, were shown to stimulate cytolytic T-lymphocyte lysis in the context of HLA A*0201. Based on an intracellular gamma interferon response, IE1p297-304, a previously unrecognized CD8 epitope, triggered a prominent response to CMV IE1 in HLA A*0201 subjects.
* Corresponding author. Mailing address: Beckman Research Institute of the City of Hope, Department of Virology, 1500 E. Duarte Rd., Duarte, CA 91010. Phone: (626) 301-8434. Fax: (626) 301-8458. E-mail:
jzaia{at}coh.edu.
Journal of Virology, April 2003, p. 4457-4462, Vol. 77, No. 7
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.7.4457-4462.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mersseman, V., Besold, K., Reddehase, M. J., Wolfrum, U., Strand, D., Plachter, B., Reyda, S.
(2008). Exogenous introduction of an immunodominant peptide from the non-structural IE1 protein of human cytomegalovirus into the MHC class I presentation pathway by recombinant dense bodies. J. Gen. Virol.
89: 369-379
[Abstract]
[Full Text]
-
Blancou, P., Mallone, R., Martinuzzi, E., Severe, S., Pogu, S., Novelli, G., Bruno, G., Charbonnel, B., Dolz, M., Chaillous, L., van Endert, P., Bach, J.-M.
(2007). Immunization of HLA Class I Transgenic Mice Identifies Autoantigenic Epitopes Eliciting Dominant Responses in Type 1 Diabetes Patients. J. Immunol.
178: 7458-7466
[Abstract]
[Full Text]
-
Besold, K., Frankenberg, N., Pepperl-Klindworth, S., Kuball, J., Theobald, M., Hahn, G., Plachter, B.
(2007). Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion. J. Gen. Virol.
88: 1429-1439
[Abstract]
[Full Text]
-
Pajot, A., Pancre, V., Fazilleau, N., Michel, M.-L., Angyalosi, G., Ojcius, D. M., Auriault, C., Lemonnier, F. A., Lone, Y.-C.
(2004). Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules. Int Immunol
16: 1275-1282
[Abstract]
[Full Text]
-
Wang, Z., La Rosa, C., Mekhoubad, S., Lacey, S. F., Villacres, M. C., Markel, S., Longmate, J., Ellenhorn, J. D. I., Siliciano, R. F., Buck, C., Britt, W. J., Diamond, D. J.
(2004). Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells. Blood
104: 847-856
[Abstract]
[Full Text]